← brief for 2026-09-29 · Slowing decline

Urogenital Infection Risk Associated With SGLT2 Inhibitors Versus DPP-4 Inhibitors in Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Target Trial Emulation.

Article C Peer reviewed Observational

Key takeaways

This study used health records from Korea to check if a common kidney drug causes more urinary tract infections. It compared people who started this drug with people who took a different diabetes drug. The records showed no higher risk of infection for the kidney drug group. This shows a link, but it is not proof of cause.

Who did this work

Ah YM · Nam J · Youn JW · Yu YM · Kang S

Source

Article · PubMed, the drug frontier · 2026 Sep 28
https://pubmed.ncbi.nlm.nih.gov/42806614/